The Safety, Tolerability and Pharmacokinetic Study of RAY1225
Clinical trial NCT05835752 · COMPLETED
Trial details
- NCT number
- NCT05835752
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-18
- Primary completion
- 2024-03-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.